# EDGAR Filing Document

**Accession Number:** 0001938373
**File Stem:** 0001213900-25-052700
**Filing Date:** 2025-6
**Character Count:** 6263
**Document Hash:** 44eb1c927ff7f32f9ef08f6e3388a251
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-052700.hdr.sgml**: 20250609

**ACCESSION NUMBER**: 0001213900-25-052700

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250609

**DATE AS OF CHANGE**: 20250609

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Rafael Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001713863
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 822296593
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90440
- **FILM NUMBER:** 251035099

**BUSINESS ADDRESS:**
- **STREET 1:** 520 BROAD STREET
- **CITY:** NEWARK
- **STATE:** NJ
- **ZIP:** 07120
- **BUSINESS PHONE:** 212-658-1450

**MAIL ADDRESS:**
- **STREET 1:** 520 BROAD STREET
- **CITY:** NEWARK
- **STATE:** NJ
- **ZIP:** 07120
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** i9 PLUS, LLC
- **CENTRAL INDEX KEY:** 0001938373

**ORGANIZATION NAME:**
- **EIN:** 853139380
- **STATE OF INCORPORATION:** DE

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 153 BOOTH AVE
- **CITY:** ENGLEWOOD
- **STATE:** NJ
- **ZIP:** 07631
- **BUSINESS PHONE:** 201-567-0225

**MAIL ADDRESS:**
- **STREET 1:** 153 BOOTH AVE
- **CITY:** ENGLEWOOD
- **STATE:** NJ
- **ZIP:** 07631

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**RAFAEL HOLDINGS, INC.**

*(Name of Issuer)*

**Class B Common Stock, par value $0.01 per share**

*(Title of Class of Securities)*

**75062E106**

*(CUSIP Number)*

**Shmuel Jonas**<br>I9 Plus, LLC<br>153 Booth Avenue<br>Englewood NJ 07631<br>(973) 438-4800

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**06/05/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **75062E106** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**I9 Plus, LLC** | Name of reporting person<br>**I9 Plus, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**3616431.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**3616431.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3616431.00** | Aggregate amount beneficially owned by each reporting person<br>**3616431.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**7%** | Percent of class represented by amount in Row (11)<br>**7%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class B Common Stock, par value $0.01 per share

**(b) Name of Issuer:**
RAFAEL HOLDINGS, INC.

**(c) Address of Issuer's Principal Executive Offices:**
520 Broad Street, Newark, NJ, 07102

This Amendment No. 1 to Schedule 13D (this "Amendment") supplements and amends the information contained in the Schedule 13D originally filed with the Securities and Exchange Commission (the "Commission") on July 18, 2025, (the "Schedule 13D").  Terms used but not defined herein shall have the meanings ascribed thereto in the Schedule 13D.  This Amendment No. 1 amends Items 3, 4 and 5, as set forth below.

**Item 4. Purpose of Transaction**

Item 4 is hereby amended and supplemented as follows:

On August 5, 2022, I9 Plus sold 33,100 shares of Class B Common Stock, pursuant to a Rule 10b5-1 plan adopted on July 19, 2022 (the "10b5-1 Plan").

On August 8, 2022, I9 Plus sold 14,787 shares of Class B Common Stock, pursuant to the 10b5-1 Plan.

On August 9, 2022, I9 Plus sold 64,674 shares of Class B Common Stock, pursuant to the 10b5-1 Plan.

On June 5, 2025, pursuant to a Standby Purchase Agreement, entered into on May 6, 2025, between Rafael Holdings, Inc. (the "Company") and Howard S. Jonas ("H. Jonas"), in connection with a rights offering undertaken by the Company, I9 Plus purchased 390,625 shares of Class B Common Stock.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Items 5 is hereby amended by deleting it in its entirety and substituting the following therefor:

As of the date hereof, I9 Plus is the beneficial owner, and has the sole power to vote, or to direct the voting, and to dispose, or direct the disposition, of 3,616,431 shares of the Company's Class B Common stock.  This number represents approximately 7% of the issued and outstanding Shares as of June 9, 2025 (including shares issued pursuant to the Standby Purchase Agreement).

**(b)**
—

**(c)**
—

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** I9 Plus, LLC

**Signature:** /s/ Shmuel Jonas

**Name/Title:** Shmuel Jonas, Manager

**Date:** 06/09/2025